Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transfusion purpura

K P Phadke, J P Isbister

    The Medical Journal of Australia
    |May 3, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Post-transfusion purpura occurred in two multiparous women due to anti-PIA1 antibodies. Both patients recovered, highlighting the antibody

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Descriptive characteristics and in-hospital mortality of critically bleeding patients requiring massive transfusion: results from the Australian and New Zealand Massive Transfusion Registry.

    Vox sanguinis·2017
    Same author

    Evaluation of clinical coding data to determine causes of critical bleeding in patients receiving massive transfusion: a bi-national, multicentre, cross-sectional study.

    Transfusion medicine (Oxford, England)·2016
    Same author

    Improving outcomes for hospital patients with critical bleeding requiring massive transfusion: the Australian and New Zealand Massive Transfusion Registry study methodology.

    BMC research notes·2016
    Same author

    What factors contribute to hospital variation in obstetric transfusion rates?

    Vox sanguinis·2014
    Same author

    Elucidating the clinical characteristics of patients captured using different definitions of massive transfusion.

    Vox sanguinis·2014
    Same author

    Comparing apples with oranges: A. M. Beliaev, R. J. Marshall, et al. (2011). 'Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia.' Vox Sang.

    Vox sanguinis·2012
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    Same journal

    Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

    The Medical journal of Australia·2026
    Same journal

    Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

    The Medical journal of Australia·2026
    Same journal

    Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

    The Medical journal of Australia·2026
    See all related articles

    Area of Science:

    • Immunology
    • Hematology
    • Transfusion Medicine

    Background:

    • Post-transfusion purpura (PTP) is a rare but serious complication following blood transfusion.
    • It is characterized by severe thrombocytopenia occurring approximately one week after transfusion.
    • PTP is typically caused by an antibody against the human platelet antigen-1a (HPA-1a).

    Purpose of the Study:

    • To describe two cases of post-transfusion purpura in multiparous women.
    • To highlight the detection of anti-HPA-1a antibodies in these patients.
    • To discuss the therapeutic approaches for this condition.

    Main Methods:

    • Case report of two multiparous women presenting with symptoms of PTP.
    • Serological testing for anti-platelet antibodies, specifically anti-HPA-1a.

    Related Experiment Videos

  • Review of treatment strategies including corticosteroids and plasma exchange.

    • Main Results:

    • Both patients were diagnosed with PTP and tested positive for anti-HPA-1a antibodies.
    • Both patients recovered from the episode of PTP.
    • The underlying mechanism involves the destruction of autologous platelets by the alloantibody.

    Conclusions:

    • Anti-HPA-1a alloantibody is a significant cause of post-transfusion purpura in multiparous women.
    • While recovery occurred in these cases, the role of specific therapies like steroids and plasma exchange remains debated.
    • Combination therapy with steroids and plasma exchange may be considered for managing PTP.